Creative Planning
STLN icon

Creative Planning’s Starling Oncology STLN Stock Holding History

Creative Planning’s Portfolio STLN Stock Details STLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$894K Buy
141,507
+31,582
+29% +$189K ﹤0.01% 2841
2026
Q2 		$597K Buy
109,925
+83,713
+319% +$352K ﹤0.01% 3064
2026
Q1 		$80.5K Sell
26,212
-52,421
-67% -$161K ﹤0.01% 3936
2025
Q4 		$280K Buy
+78,633
New +$292K ﹤0.01% 3292

Other funds holding STLN

Kingswood Wealth Advisors
Kingswood Wealth Advisors San Diego, California $2.6B AUM 27.46% 1-Year Est. Return
State of Wyoming
State of Wyoming Cheyenne, Wyoming $1.29B AUM 32.25% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $67.3B AUM 21.9% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
Allspring Global Investments
Allspring Global Investments Charlotte, North Carolina $64.1B AUM 28.9% 1-Year Est. Return
Berkshire Money Management
Berkshire Money Management Dalton, Massachusetts $1.16B AUM 13.8% 1-Year Est. Return
Granite Investment Partners
Granite Investment Partners El Segundo, California $1.84B AUM 35.93% 1-Year Est. Return
Pekin Hardy Strauss
Pekin Hardy Strauss Chicago, Illinois $1.14B AUM 25.53% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Fermata Advisors
Fermata Advisors Sonoma, California $517M AUM 14.47% 1-Year Est. Return

Creative Planning's STLN Position: Q3 2026 in Review

Creative Planning increased its Starling Oncology (STLN) stake by 29% in Q3 2026, buying an estimated $189K and bringing the position to 141,507 shares worth $894K. The position accounts for ﹤0.01% of the portfolio, ranked #2841.

Creative Planning first reported a position in STLN in Q4 2025 and has held it in 4 quarters since. 25 funds tracked by Wall St. Rank hold STLN as of Q3 2026.

  • Creative Planning held 141,507 shares of Starling Oncology worth $894K as of Q3 2026.
  • Creative Planning bought 31,582 Starling Oncology shares in Q3 2026, an estimated $189K.
  • Starling Oncology made up ﹤0.01% of Creative Planning's portfolio in Q3 2026, its #2841 holding.
  • Creative Planning first reported a position in Starling Oncology in Q4 2025 and has held it in 4 quarters since.
  • 25 funds tracked by Wall St. Rank held Starling Oncology as of Q3 2026.

Based on Creative Planning's 13F filing for Q3 2026, filed 2 Nov 2026.